Progress and Hope: The Path to Ending HIV/AIDS
The pursuit of a "functional cure" for HIV is gaining momentum, with recent clinical trials at Rockefeller University exploring the use of broadly neutralizing antibodies to maintain viral suppression without antiretroviral treatment. While complete eradication of the virus remains challenging due to its ability to hide in the body's cells, these antibodies show promise in targeting the HIV reservoir. The trials have demonstrated that some participants can maintain viral suppression for extended periods, offering hope for a future where HIV can be managed with less frequent treatments. The research underscores the importance of inclusivity in clinical trials to ensure treatments are effective for all demographics.
